Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients.
about
Topical antibiotics as a major contextual hazard toward bacteremia within selective digestive decontamination studies: a meta-analysisA Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent CohortsExhaled breath profiling for diagnosing acute respiratory distress syndrome.The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative.Nebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort studyThe attributable mortality of delirium in critically ill patients: prospective cohort study.How well do discharge diagnoses identify hospitalised patients with community-acquired infections?--a validation study.The Impact of HIV Co-Infection on the Genomic Response to Sepsis.Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study.Improving ventilator-associated event surveillance in the National Healthcare Safety Network and addressing knowledge gaps: update and review.Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients.Quantifying the improvement in sepsis diagnosis, documentation, and coding: the marginal causal effect of year of hospitalization on sepsis diagnosis.Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis.Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome.The predictive value of early acute kidney injury for long-term survival and quality of life of critically ill patients.Does ventilator-associated event surveillance detect ventilator-associated pneumonia in intensive care units? A systematic review and meta-analysis.Exhaled Breath Metabolomics for the Diagnosis of Pneumonia in Intubated and Mechanically-Ventilated Intensive Care Unit (ICU)-Patients.Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study.Impact of HIV infection on the presentation, outcome and host response in patients admitted to the intensive care unit with sepsis; a case control study.Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients.Transfusion of platelets, but not of red blood cells, is independently associated with nosocomial infections in the critically ill.Epidemiology, Management, and Risk-Adjusted Mortality of ICU-Acquired Enterococcal Bacteremia.Electronic implementation of a novel surveillance paradigm for ventilator-associated events. Feasibility and validation.Potential Strategies to Prevent Ventilator-associated Events.The Host Response in Patients with Sepsis Developing Intensive Care Unit-acquired Secondary Infections.Does CDC's Ventilator Associated Event Definition Unintentionally Contradict its Antimicrobial Stewardship Initiative?Epidemiology of Multiple Herpes Viremia in Previously Immunocompetent Patients With Septic Shock.Risk factors, host response and outcome of hypothermic sepsis.Comparative Analysis of the Host Response to Community-acquired and Hospital-acquired Pneumonia in Critically Ill Patients.Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.Discordance between novel and traditional surveillance definitions for ventilator-associated pneumonia: insights and opportunities to improve patient care.Risk stratification using SpO2/FiO2 and PEEP at initial ARDS diagnosis and after 24 h in patients with moderate or severe ARDS.Ventilator-associated conditions versus ventilator-associated pneumonia: different by design.Associations Between Enteral Colonization With Gram-Negative Bacteria and Intensive Care Unit-Acquired Infections and Colonization of the Respiratory Tract.The host response in critically ill sepsis patients on statin therapy: a prospective observational study.Selective decontamination of the digestive tract halves the prevalence of ventilator-associated pneumonia compared to selective oral decontamination.Macrolide therapy is associated with reduced mortality in acute respiratory distress syndrome (ARDS) patients.Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update.Development and first evaluation of a novel multiplex real-time PCR on whole blood samples for rapid pathogen identification in critically ill patients with sepsis.
P2860
Q26998525-729D854A-E758-4F03-9C12-21C1773374C3Q28606587-3F8E9136-E0C9-41B0-A0C8-5D4D84ECF6B0Q33613793-33BD9EDE-6613-4854-8E5D-09721E682DBEQ33735582-15CEBE5A-B5F6-4D88-BF7A-8482CCEADBC3Q33750223-A7998C21-13BD-4DE2-BDDF-6AD391761F0AQ34567596-222C67D7-3BD5-41F5-9762-3541C086B47FQ35129370-944B5E7F-A604-46BA-84F1-C788A590F7E0Q35922190-317CF04F-DFA5-4B10-B293-7529A7C6A569Q36035706-D1A76FDF-6635-459A-BF93-BEB8BAF28E0AQ36263634-0C27BD85-79D2-46ED-BD2B-F1ED4D1E5D22Q36317219-3986FFD4-71D1-457C-AA4C-77278CE78AACQ36395980-B8900AE1-B8FD-40C8-BE89-9BE79D68D904Q36564241-1327791E-8F68-45FB-BDEA-8EA2DC4703CFQ36564294-F80CFA48-632D-4A24-AD53-2F79DF17FE77Q37150926-B4AEA9F9-D156-4092-94F9-F8FAE3797EA4Q37360017-7BE31B1B-10CD-4E3D-B8B5-2909E0FAC67DQ37691060-94F73C22-1E36-4D69-B83E-C51737534601Q38432516-4C2BF4B8-102E-4434-A43C-08D2F211AFB3Q38435684-77F1A86E-8EB0-4DF5-BBF5-BFB952CAB9EFQ38436645-419F6891-A4B1-45D3-BA1D-C32EBDBEA965Q38437038-31834DF6-0E83-405F-83CF-061E62443221Q38442969-BFF7904B-1F4A-41B8-BA3D-7980F9BCE9E7Q38450738-70CE4AAE-31C4-432C-A971-DD4214E6790BQ38591718-4E979CBF-C128-4E49-BFB6-6B1AE53443D1Q39010121-4E723082-39BE-4B74-9597-AD71E99EE702Q40181392-64FDACBC-FB4F-479F-992C-94346CBF6D1CQ40346711-4F17839C-0EF1-40F0-AD13-8006CF906255Q40507915-3628F0FF-32C3-43FA-8F17-67E42EF4A563Q40643505-332DE05D-3830-4F43-BC95-4A2DA246CE9EQ40765104-086F24BD-2999-4D4B-8B1E-D5959EB3B668Q41650084-E82E804C-7495-4546-AB01-E14F324AFEF2Q43599790-6005E54C-DFB6-4846-BE9E-00FC179A12D1Q45416879-32EC7F16-0439-42F5-936F-FB1590D29A68Q46528310-0C8A5AB7-512E-48BB-8981-CA73F724C8B8Q47593690-F06EB3E9-0AD3-48D9-8A64-E916AF80F018Q47653153-C1B18B7F-1C2A-4315-9A5C-992D728DC2F6Q47894003-0C895E2D-48C9-44D0-9F80-65E9B17D34F2Q50072815-D3F01DE1-4FDF-415E-B157-B005455F530EQ51710565-CEDC349E-DCDD-4966-A4BC-C640D828904BQ52559854-1C12BD87-E5B7-4B7A-8BCA-1124C65A9DE0
P2860
Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interobserver agreement of Cen ...... ns in critically ill patients.
@en
type
label
Interobserver agreement of Cen ...... ns in critically ill patients.
@en
prefLabel
Interobserver agreement of Cen ...... ns in critically ill patients.
@en
P2093
P50
P1476
Interobserver agreement of Cen ...... ns in critically ill patients.
@en
P2093
David S Y Ong
Friso M de Beer
Lieuwe D J Bos
Lonneke A van Vught
Luuk Wieske
Marc J M Bonten
Marleen Straat
Mischa A Huson
Olaf L Cremer
Roosmarijn T M van Hooijdonk
P304
P356
10.1097/CCM.0B013E3182923712
P407
P577
2013-10-01T00:00:00Z